Hi-Tech Pharmacal Co., Inc.Amityville, NY, United States (NASDAQ (GS): HITK)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Hi-Tech Pharmacal Financial Statements

Hi-Tech Pharmacal Financial Information

Company Type Public
Headquarters
Fiscal Year-End April
© 2009 Morningstar, Inc. Financial Data provided by Morningstar

Hi-Tech Pharmacal Income Statement

  2009 2008 2007
Revenue ($ mil.) 108.7 62.0 58.9
Gross Profit ($ mil.) 51.7 21.5 23.2
Operating Income ($ mil.) 15.9 (6.8) (4.0)
Total Net Income ($ mil.) 9.8 (5.1) (2.0)
Diluted EPS (Net Income) 0.84 (0.45) (0.17)
More Hi-Tech Pharmacal financial information

Hi-Tech Pharmacal Quarterly Statements

  Quarter Ending Jul 09 Quarter Ending Apr 09 Quarter Ending Jan 09
Revenue ($ mil.) 43.5 38.3 29.4
Gross Profit ($ mil.) 26.6 19.9 13.8
Operating Income ($ mil.) -- 7.8 3.5
Total Net Income ($ mil.) 8.7 5.1 2.1
Diluted EPS (Net Income) 0.73 0.44 0.18
More Hi-Tech Pharmacal financial information

Hi-Tech Pharmacal Stock Quote & Chart

11/06/09 16:00:01 EST • NASDAQ • 19.86 • Increased by 0.0000 • Increased by 0.0000 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Hi-Tech Pharmacal Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 1.70 1.15 7.01
Price/Earnings Ratio 13.64 23.98 25.51
Price/Book Ratio 2.37 1.73 6.74
Price/Cash Flow Ratio 27.32 9.29 43.48
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Hi-Tech Pharmacal Financial Ratios

Hi-Tech Pharmacal Competitive Intelligence

Mylan Teva Pharmaceuticals USA Watson Pharmaceuticals
Annual Sales ($ mil.) 5,137.6 0.0 2,535.5
Employees 15,000 1,025 5,070
Market Cap ($ mil.) 5,323.3 -- 3,739.6

Competitive Landscape

Copyright © 2009, Hoover's, Inc., All Rights Reserved. Legal Terms | Privacy Policy